期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
AN EVALUATION OF THE IOP CHANGES IN PATIENTS SWITCHED FROM BETA BLOCKER MONOTHERAPY OR COMBI-NATION THERAPY TO TRAVATAN IN THE S.T.A.R.T. TRIAL
1
作者 P.Schacknow J.T.Przydryga Start Study Group 《国际眼科杂志》 CAS 2003年第1期80-80,共1页
Objective: S.T.A.R.T. (Study of Travatan as Replacement Therapy) is an open label, multi-center, prospective, four week trial to evaluate the IOP lowering efficacy of Travatan (travoprost ophthalmic solution, 0.004%) ... Objective: S.T.A.R.T. (Study of Travatan as Replacement Therapy) is an open label, multi-center, prospective, four week trial to evaluate the IOP lowering efficacy of Travatan (travoprost ophthalmic solution, 0.004%) in patients requiring prostaglandin analogue therapy. This analysis reports on patients that were 展开更多
关键词 青光眼患者 Β-阻滞剂 单一疗法 联合治疗 转换 曲福前列素 替代疗法 iop变化 评价
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部